Factors Associated With Immune Checkpoint Inhibitor–Related Myocarditis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Factors Associated With Immune Checkpoint Inhibitor–Related Myocarditis

Published:2019-11-01 Issue:11 Volume:5 Page:1635
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Zamami Yoshito¹²,Niimura Takahiro¹,Okada Naoto²,Koyama Toshihiro³,Fukushima Keijo⁴,Izawa-Ishizawa Yuki⁵,Ishizawa Keisuke¹²

Affiliation:

1. Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan

2. Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan

3. Department of Pharmaceutical Biomedicine, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan

4. Department of Pharmacology for Life Sciences, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan

5. AWA Support Center, Tokushima University, Tokushima, Japan

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2748891/jamaoncology_zamami_2019_ld_190016.pdf

Reference6 articles.

1. Fulminant myocarditis with combination immune checkpoint blockade.;Johnson;N Engl J Med,2016

2. Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study.;Salem;Lancet Oncol,2018

3. The effects of gender and age on occurrence of clinically suspected myocarditis in adulthood.;Kytö;Heart,2013

4. Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab.;Menzies;Ann Oncol,2017

5. Sex differences in tolerability to anti-PD1 therapy: are we all equal?;Duma;J Clin Oncol,2018

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the association between fluoroquinolones and aortic diseases using real-world database analysis and pharmacological experiments;Biomedicine & Pharmacotherapy;2024-10

2. Toxicity in the era of immune checkpoint inhibitor therapy;Frontiers in Immunology;2024-08-23

3. Immune Checkpoint Inhibitor–Induced Cardiotoxicity;JAMA Oncology;2024-08-22

4. Toxicity profile of camrelizumab-based immunotherapy in older adults with advanced cancer;Scientific Reports;2024-08-16

5. Preclinical models of cardiotoxicity from immune checkpoint inhibitor therapy;Basic Research in Cardiology;2024-07-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3